CTRI/2019/01/017085
Not yet recruiting
未知
Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing in Lung cancer
TMAI PAI ENDOWMENT CHAIR0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- TMAI PAI ENDOWMENT CHAIR
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Newly diagnosed cases of lung cancer.
- •2\.Age \<70 years and \> 18 years of age.
- •3\.Patients who are willing to give informed consent.
- •4\.Patients who have not received Chemotherapy or Radiotherapy for treatment before.
Exclusion Criteria
- •1\.Age more than 70 and less than 18 years of age.
- •2\.Patients not willing to give informed consent.
- •3\.Patients who have received Chemotherapy or Radiotherapy for treatment before.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Identification of Genetic Changes in Indian Lung Cancer PatientsHealth Condition 1: C34- Malignant neoplasm of bronchus andlungCTRI/2019/12/022284DST INSPIRE Fellowship
Recruiting
Not Applicable
A Phase III Trial of Treatment Intensification in Stage II-III Colon Cancer Patients with Positive MRD during Adjuvant ChemotherapyKCT0007644Seoul National University Hospital236
Recruiting
Not Applicable
Circulating tumor DNA (ctDNA) analyses as a predictive marker for cancer treatment in solid tumorsKCT0008188Chonnam National University Hospital Hwasun Hospital100
Not yet recruiting
Not Applicable
Brain tumor biomarker studyHealth Condition 1: C719- Malignant neoplasm of brain, unspecifiedCTRI/2021/01/030566Johns Hopkins University School of Medicine
Recruiting
Not Applicable
Quantification of Circulating tumor DNA to assess treatment response in metastatic prostate cancer patientsmetastatic prostate cancerNL-OMON24467Erasmus Medical Center95